HONG KONG (Reuters) - A renewed push by the central government to expand healthcare reforms and restrict costs for end users is putting pressure on margins for a growing number of Chinese drugmakers.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/NQWj-bFnTRw/us-china-pharma-outlook-idUSTRE8210CY20120302
best news online money internet business Current news latest news top news
No comments:
Post a Comment